More about
Left Ventricular Thrombus
News
March 29, 2025
3 min read
Save
Rivaroxaban a ‘viable alternative’ to warfarin for blood clots after heart attack
CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated with warfarin.
News
December 12, 2024
5 min read
Save
Anticoagulation stewardship: Considerations for patients with cardiovascular disease
Anticoagulants are one of the most commonly prescribed medication classes, and the utilization of these agents is on the rise.